Patents by Inventor Michael F. Ward

Michael F. Ward has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250223365
    Abstract: The present disclosure is generally directed to the use of compositions that include antibodies, e.g., monoclonal, chimeric, affinity-matured, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a Sortilin protein, e.g., human Sortilin or mammalian Sortilin, and have improved and/or enhanced functional characteristics, in treating and/or delaying progression of a disease or injury in an individual in need thereof.
    Type: Application
    Filed: July 18, 2024
    Publication date: July 10, 2025
    Applicant: Alector LLC
    Inventors: Robert PAUL, Michael F. WARD, Hua LONG, Shiao-Ping LU, Omer Rizwan SIDDIQUI, Arnon ROSENTHAL, Herve RHINN
  • Publication number: 20250084165
    Abstract: The present disclosure is generally directed to the use of compositions that include antibodies, e.g., monoclonal, chimeric, affinity-matured, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a TREM2 protein, e.g., human TREM2, and have improved and/or enhanced functional characteristics, in treating and/or delaying progression of a disease or injury in an individual in need thereof.
    Type: Application
    Filed: August 15, 2024
    Publication date: March 13, 2025
    Applicant: Alector LLC
    Inventors: Michael F. WARD, Sam JACKSON
  • Publication number: 20240329054
    Abstract: The present disclosure relates generally to biomarkers of activity and/or therapeutic efficacy of anti-CD33 antibodies for the treatment of a disease or injury in an individual, as well as methods related thereto.
    Type: Application
    Filed: May 6, 2024
    Publication date: October 3, 2024
    Applicant: Alector LLC
    Inventors: Robert PAUL, Michael F. WARD, Felix Leejia YEH, Yijie LIAO, Herve RHINN, Arnon ROSENTHAL
  • Publication number: 20240132597
    Abstract: The present disclosure is generally directed to the use of compositions that include antibodies, e.g., monoclonal, chimeric, affinity-matured or humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a Sortilin protein, e.g., human Sortilin or mammalian Sortilin, and have improved and/or enhanced functional characteristics, in treating and/or delaying progression of a disease or injury in an individual in need thereof.
    Type: Application
    Filed: December 7, 2023
    Publication date: April 25, 2024
    Applicant: Alector LLC
    Inventors: Robert PAUL, Sam JACKSON, Omer Rizwan SIDDIQUI, Michael F. WARD, Felix Leejia YEH, Julie Y. HUANG, Whedy WANG, Yijie LIAO, Brian C. MANGAL
  • Publication number: 20240101681
    Abstract: The present disclosure is generally directed to the use of antibodies that specifically bind one or more epitopes within a sortilin protein, e.g., human sortilin or mammalian sortilin, for treating and/or delaying progression of a disease, disorder, or injury in an individual in need thereof.
    Type: Application
    Filed: December 1, 2021
    Publication date: March 28, 2024
    Applicant: Alector LLC
    Inventors: Arnon ROSENTHAL, Felix Leejia YEH, Michael F. WARD, Robert PAUL, Hua LONG, Yijie LIAO
  • Publication number: 20230183341
    Abstract: The present disclosure is generally directed to the use of compositions that include antibodies, e.g., monoclonal, chimeric, affinity-matured, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a TREM2 protein, e.g., human TREM2, for use in treating and/or delaying progression of a disease or injury in an individual in need thereof.
    Type: Application
    Filed: April 2, 2021
    Publication date: June 15, 2023
    Applicant: Alector LLC
    Inventors: Robert PAUL, Michael F. WARD, Hua LONG, Omer Rizwan SIDDIQUI, Arnon ROSENTHAL, Felix Leejia YEH, Sam JACKSON
  • Publication number: 20230035072
    Abstract: The present disclosure is generally directed to antibodies, e.g., monoclonal, chimeric, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a CD33 protein, e.g., human CD33 or a mammalian CD33, and have improved and/or enhanced functional characteristics. The present disclosure is further directed to the methods of treating and/or delaying the progression of a disease or injury in an individual by administering such antibodies.
    Type: Application
    Filed: December 11, 2020
    Publication date: February 2, 2023
    Applicant: Alector LLC
    Inventors: Robert PAUL, Michael F. WARD, Hua LONG, Shiao-Ping LU, Omer Rizwan SIDDIQUI, Arnon ROSENTHAL
  • Publication number: 20200392229
    Abstract: The present disclosure is generally directed to the use of compositions that include antibodies, e.g., monoclonal, chimeric, affinity-matured, humanized antibodies, antibody fragments, etc., that specifically bind one or more epitopes within a Sortilin protein, e.g., human Sortilin or mammalian Sortilin, and have improved and/or enhanced functional characteristics, in treating and/or delaying progression of a disease or injury in an individual in need thereof.
    Type: Application
    Filed: June 10, 2020
    Publication date: December 17, 2020
    Applicant: Alector LLC
    Inventors: Robert PAUL, Michael F. WARD, Hua LONG, Shiao-Ping LU, Omer Rizwan SIDDIQUI, Arnon ROSENTHAL, Herve RHINN
  • Publication number: 20020179089
    Abstract: A method and system for breathing gas heat exchange for use with an underwater pressurized gas source connected to a breathing apparatus comprising a length of tubing sufficient in diameter and length to allow heat exchange of expanding gas from the pressurized source to the breathing apparatus in order to substantially increase the temperature of the expanding gas. The tubing being made of a heat conducting material and being wholly unenclosed and open for contact with ambient fluid within which the method and system is used.
    Type: Application
    Filed: February 14, 2001
    Publication date: December 5, 2002
    Inventors: William B. Morgan, Michael F. Ward, Trent M. Schultz, Peter M. Ryan